SEC EDGAR Filing Information

Form EFFECT --

Effectiveness Date: 2006-05-26
Registration Form: SB-2
Documents: 1

SEC Accession No.
9999999995-06-000099
Accepted: 2006-05-30 00:15:21

Table of submitted documents:

Seq	Type	Document	Size	Description
1	EFFECT	primary_doc.html
1	EFFECT	primary_doc.xml	514

		9999999995-06-000099.txt	2218	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-133975 | Film No.: 06871967
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
1691 MICHIGAN AVE.
SUITE 435
MIAMI FL 33139
305-534-3383

Mailing Address
1691 MICHIGAN AVE.
SUITE 435
MIAMI FL 33139